Laique, Ali Aminian Diabetes, Obesity and Metabolism .2026;[Epub] CrossRef Trends in MASLD-related cirrhosis and liver cancer across diverse populations, 20102023 Jialin Wu, Bonan Chen, Fuda Xie, Jiahui Hu, Mingyu Liang, Yang Lyu, Peiyao Yu, Tiejun Feng, Muyang Huang, Canbin Fang, Ka Fai To, Terry Cheuk-Fung Yip, Xingxin Wang, Wei Kang Hepatology International .2026;[Epub] CrossRef Letter to the Editor: Steatotic liver disease in chronic hepatitis C - a marker of systemic risk, not direct-acting antiviral treatment failure Abdo Imad El Tawil, Claudia Alexandra Pontes Ivantes World Journal of Hepatology .2026;[Epub] CrossRef Metabolic Dysfunction-Associated Steatotic Liver Disease in Inflammatory Bowel Disease: A Cross-Sectional Study of Prevalence and Associated Factors Hseyin Aykut, Nermin Mutlu Bilgi, Duygu Demirta, Sleyman Sayar, Kamil zdil Metabolites .2026
Pricing Medication Costs Insurance PeterMD only accepts cash payments for NAD+
Platinum nanoparticles: tiny titans in therapy
1 (download XLSX Numerical data for kinetics experiments
The compounded version contains the same active ingredient but is prepared by a compounding pharmacy rather than the original manufacturer
NNMT transfers a methyl group from SAM onto nicotinamide, producing 1-methylnicotinamide while consuming methyl donors and contributing to NAD depletion